Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v2.4.0.8
Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Sep. 30, 2013
Series A
Jan. 14, 2013
Series A
Sep. 30, 2013
Series B
Jan. 14, 2013
Series B
Allowances for trade accounts receivable $ 39,239 $ 35,045        
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $ 103,502 $ 110,882        
Preferred Stock, Par or Stated Value Per Share $ 0.01          
Preferred Stock, Shares Authorized 50,000,000          
Preferred Stock, Shares Issued 0 0        
Preferred Stock, Shares Outstanding 0          
Common Stock, Par or Stated Value Per Share     $ 0.01   $ 0.01  
Common Stock, Shares Authorized     2,000,000,000   75,000,000  
Common Stock, Shares, Issued     104,572,952   9,875,738  
Common Stock, Shares, Outstanding     104,572,952 111,722,828 9,875,738 9,882,238